95 patents
Utility
Methods of Synthesizing Cannabigergol, Cannabigerolic Acid, and Analogs Thereof
4 Jan 24
Disclosed are methods for preparing cannabigerol (CBG) or a CBG analog, embodiments of the method comprising providing a compound (I); combining the compound (I) with geraniol and a solvent to form a reaction mixture; and combining the reaction mixture with an acid catalyst to form a product mixture comprising the CBG or the CBG homolog.
Daniel BRUMAR, Mahmood Azizpour FARD, Ben GEILING, Mohammadmehdi HAGHDOOST MANJILI
Filed: 15 Sep 23
Utility
Cannabis Plant with Increased Cannabichromenic Acid
28 Dec 23
The present technology generally relates to Cannabis plants having increased cannabichromenic acid (CBCA) and/or cannabichromene (CBC) content as well as to nucleic acids related to same and methods of producing same.
Daniel Kevin FOWLER
Filed: 13 Oct 21
Utility
Cannabinoid Derivatives
14 Sep 23
This disclosure relates generally to cannabinoid derivatives having the structural formula (I), pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives.
SIAWASH AHMAR, JUNG YUN KIM, PING SHAN LAI, JEFFREY ALAN OMEARA, AZADEH PIRI SEDIGH, QUANG HUY TO
Filed: 25 Nov 20
Utility
Cannabigerol Derivatives and Use Thereof As Cannabinoid Receptor Modulators
18 May 23
The synthesis of a range of pentylbezene-1,3-diol compounds of formula I is disclosed.
SIAWASH AHMAR, KRISHNA KUMAR GNANASEKARAN, JEFFREY ALAN OMEARA
Filed: 25 Nov 20
Utility
Methods of Synthesizing Cannabielsoin and Analogs Thereof
11 May 23
Disclosed are methods for synthesizing cannabielsoin (CBE) and or analogs thereof.
Mahmood Azizpour FARD, Ben GEILING, Mohammadmehdi HAGHDOOST MANJILI
Filed: 26 Jul 21
Utility
Cannabinoid Derivatives
4 May 23
This disclosure relates to cannabinoid derivatives having the structure of formula (I), pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives in treating or preventing a diseases associated with a cannabinoid receptor in subject in need thereof, wherein the cannabinoid receptor is one or more of CB1, CB2, 5HT1A, 5HT2A, GPR18, GPR55, GPR119, TRPV1, TRPV2, PPARγ or a μ-opioid receptor.
SIAWASH AHMAR, KRISHNA KUMAR GNANASEKARAN, JEFFREY ALAN OMEARA, JI SUNG PARK
Filed: 10 Jul 20
Utility
Cannabinoid Salt Compounds and Methods of Making Same
4 May 23
Disclosed herein are cannabinoid salt compounds formed by mixing an acidic cannabinoid compound with a base.
Mahmood Azizpour FARD, Ben GEILING, Mohammadmehdi HAGHDOOST MANJILI
Filed: 23 Jul 21
Utility
Cannabinoid Derivatives
20 Apr 23
This disclosure relates generally to cannabinoid derivatives of formula (I), pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives for the treatment of conditions associated with cannabinoid receptor.
SIAWASH AHMAR, JEFFREY ALAN OMEARA, PETER MARTIN DOVE
Filed: 25 Nov 20
Utility
Methods for Converting Thc-rich Cannabinoid Mixtures into Cbn-rich Cannabinoid Mixtures
30 Mar 23
Disclosed herein is a method of converting a THC-rich cannabinoid mixture that comprises at least about 20% THC into a CBN-rich cannabinoid mixture that comprises at least about 2.0% CBN.
Christopher ADAIR, Mahmood AZIZPOOR FARD, Ben GEILING, Mohammadmehdi HAGHDOOST MANJILI
Filed: 28 Sep 22
Utility
Cannabinoid Derivatives
23 Feb 23
This disclosure relates generally to cannabinoid derivatives, pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives.
JEFFREY ALAN OMEARA, QUANG HUY TO
Filed: 27 Nov 20
Utility
Methods of Synthesizing Cannabigergol, Cannabigerolic Acid, and Analogs Thereof
9 Feb 23
Disclosed are methods for preparing cannabigerol (CBG) or a CBG analog, embodiments of the method comprising providing a compound (I); combining the compound (I) with geraniol and a solvent to form a reaction mixture; and combining the reaction mixture with an acid catalyst to form a product mixture comprising the CBG or the CBG homolog.
Daniel BRUMAR, Mahmood Azizpour FARD, Ben GEILING, Mohammadmehdi HAGHDOOST MANJILI
Filed: 8 Aug 22
Utility
Composition Comprising Cannabinoids for Relief of Pain
9 Feb 23
The present technology generally relates to compositions comprising cannabinoids for relieving pain in a subject and to methods of using such compositions for relieving pain in a subject.
Mark Andrew HETHERINGTON, Chris SCHNARR
Filed: 4 Oct 22
Utility
Cannabinoid Derivatives
26 Jan 23
The present application discloses a compound of formula (I), compositions comprising said compound, and a method of using said compound as a cannabinoid receptor ligand in the treatment or prevention of diseases associated with a cannabinoid receptor, such as, CB1, CB2, 5HT1A, 5HT2A, GPR18, GPR119, TRPV1, TPRV2, PPARγ or a μ-opioid receptor.
PATRICK THOMAS GUNNING, JEFFREY ALAN OMEARA, QUANG HUY TO
Filed: 27 Nov 20
Utility
Separation of Cannabinoids from Mixtures Thereof by Distillation
5 Jan 23
The present disclosure relates to isolating one or more cannabinoids from an input mixture.
Christopher ADAIR, Ben GEILING, Logan MARYNISSEN
Filed: 30 Jul 20
Utility
Compaction Apparatus and Related Methods
15 Dec 22
A method of compacting a smokeable product in a cone for production of smoking articles is disclosed.
BEN KAUFMANN, ROD MUIR, MIKE SIROIS, JESSICA KARA SMITH
Filed: 19 Aug 22
Utility
Cannabinoid Derivatives
3 Nov 22
This disclosure relates to cannabinoid derivatives of Formula (I), wherein R4 or R7 is a carboxamide group, pharmaceutical compositions comprising these compounds and methods of using the cannabinoid derivatives.
SIAWASH AHMAR, JUNG YUN KIM, PING SHAN LAI, JEFFREY ALAN OMEARA, QUANG HUY TO, PETER MARTIN DOVE
Filed: 2 Oct 20
Utility
Cannabinoid Derivatives
27 Oct 22
This disclosure relates generally to cannabinoid derivatives having the formula (I), wherein R4 is hydrogen, —C(Q1)N(R4a)(R4b) or —C(R4J)(R4k)N(R4e)C(0)R4f, R6 is hydrogen, —C(Q2)N(R6a)(R6b) or —C(R6J)(R6k)N(R6e)C(0)R6f, provided that R6 is not hydrogen when R4 is hydrogen.
SIAWASH AHMAR, JUNG YUN KIM, PING SHAN LAI, JEFFREY ALAN OMEARA, QUANG HUY TO
Filed: 2 Oct 20
Utility
Methods of Synthesizing High-purity Cannabicyclol and Artificial Resins Comprising Cannabicyclol
27 Oct 22
Compositions having enhanced cannabicyclol (CBL) or CBL derivative concentrations are disclosed herein as are methods of synthesizing CBL and CBL derivative in high-purity form.
Daniel BRUMAR, Ben GEILING, Mohammadmehdi HAGHDOOST MANJILI, Mark ZOLKIEWSKI
Filed: 24 Dec 20
Utility
Separation of Cannabinoids from Mixtures Thereof by Extraction and Distillation
20 Oct 22
The present disclosure relates to isolating one or more cannabinoids from an input mixture.
Christopher ADAIR, Ben GEILING, Logan MARYNISSEN
Filed: 30 Jul 20
Utility
Cannabis Tablet Formulations and Compositions and Methods of Making the Same
13 Oct 22
Disclosed herein are compositions comprising an oil having at least one cannabinoid and at least one solid powder and methods of making and using the same.
Kurt LEVY
Filed: 15 Jun 22